Loading…
Breast Density and Mammography Reporting Act of 2015
Legislative Progress
Introduced
February 4, 2015
Latest Action
February 4, 2015
Primary Sponsor
Dianne FeinsteinDemocratic(CA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,548 other S bills in the 114th — cohort avg 43d
Breast Density and Mammography Reporting Act of 2015 Amends the Public Health Service Act to require mammography facilities to include up-to-date information about breast density in both the written report of the results of a mammography examination provided to a patient's physician and the summary of that written report given to the patient. Requires the summary to convey: (1) the effect of breast density in masking the presence of breast cancer on a mammogram, and (2) that individuals with dense breasts should talk with their physicians about any questions or concerns regarding the summary and whether they would benefit from additional tests. Requires the Department of Health and Human Services to expand and intensify research on breast density, the cost-effectiveness and feasibility of supplemental imaging relating to breast density, and best practices concerning mammograms and supplemental screening for those with dense breasts.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (7)
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S775)
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2016 · fourth_quarter · Health Issues
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opioid prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments, S.3077, the Marijuana Effective Drug Studies Act of 2016.
Client expense: $1,640,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
2016 · fourth_quarter · Health Issues
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opioid prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments, S.3077, the Marijuana Effective Drug Studies Act of 2016.
Client expense: $1,620,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
2016 · fourth_quarter · Health Issues
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opioid prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments, S.3077, the Marijuana Effective Drug Studies Act of 2016.
Client expense: $1,630,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
2016 · fourth_quarter · Health Issues
Pub. Law No. 111-148, Patient Protection and Affordable Care Act, matters related to the implementation of breast health education, research and clinical trials; S.1566/H.R.2722, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients; H.R.1600, Patients' Access to Treatment Act, support amending the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure and prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier; H.R.1608, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; S.370/H.R.716, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; H.R.1925, Dr. Balazs "Ernie" Bodai Congressional Gold Medal, support the presentation of a congressional gold medal to Dr. Balaz "Ernie" Bodai in recognition of his many outstanding contributions to the nation, including a tireless commitment to breast cancer research; H.R.6, 21st Century Cures Act, issues related to cancer prevention and research funding; S.620/H.R.1189, Preserving Employee Wellness Programs Act, issues related to the Genetic Information Act of 2008 and workplace wellness programs; H.R.2846, Planning Actively for Cancer Treatments Act, support coverage of cancer care planning and coordination services; S.91/H.R.4112, Mobile Mammography Promotion Act, issues related to excluding mobile mammography vehicles from the motor fuel excise tax; H.R.3119, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care; S.1488/H.R.2624, Part D Beneficiary Appeals Fairness Act, issues related to out-of-pocket costs for prescription drugs.
Client expense: $38,415 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
2016 · fourth_quarter · Health Issues
S 370/H.R.716, the Breast Density and Mammography Reporting Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Health Issues
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opioid prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments, S.3077, the Marijuana Effective Drug Studies Act of 2016.
Client expense: $1,200,000 · Firm income: Not reported
2016 · third_quarter · Health Issues
Pub. Law No. 111-148, Patient Protection and Affordable Care Act, matters related to the implementation of breast health education, research and clinical trials; S.1566/H.R.2722, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients; H.R.1600, Patients' Access to Treatment Act, support amending the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure and prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier; H.R.1608, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; S.370/H.R.716, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; H.R.1925, Dr. Balazs "Ernie" Bodai Congressional Gold Medal, support the presentation of a congressional gold medal to Dr. Balaz "Ernie" Bodai in recognition of his many outstanding contributions to the nation, including a tireless commitment to breast cancer research; H.R.6, 21st Century Cures Act, issues related to cancer prevention and research funding; S.620/H.R.1189, Preserving Employee Wellness Programs Act, issues related to the Genetic Information Act of 2008 and workplace wellness programs; H.R.2846, Planning Actively for Cancer Treatments Act, support coverage of cancer care planning and coordination services; S.91/H.R.4112, Mobile Mammography Promotion Act, issues related to excluding mobile mammography vehicles from the motor fuel excise tax; H.R.3119, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care; S.1488/H.R.2624, Part D Beneficiary Appeals Fairness Act, issues related to out-of-pocket costs for prescription drugs.
2016 · third_quarter · Health Issues
S 370, the Breast Density and Mammography Reporting Act
Client expense: Not reported · Firm income: $10,000
Government targets: SENATE
2016 · second_quarter · Health Issues
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opiod prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments.
Client expense: $1,250,000 · Firm income: Not reported
2016 · second_quarter · Health Issues
Pub. Law No. 111-148, Patient Protection and Affordable Care Act, matters related to the implementation of breast health education, research and clinical trials; S.1566/H.R.2722, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients; H.R.1600, Patients' Access to Treatment Act, support amending the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure and prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier; H.R.1608, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; S.370/H.R.716, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; H.R.1925, Dr. Balazs "Ernie" Bodai Congressional Gold Medal, support the presentation of a congressional gold medal to Dr. Balaz "Ernie" Bodai in recognition of his many outstanding contributions to the nation, including a tireless commitment to breast cancer research; H.R.6, 21st Century Cures Act, issues related to cancer prevention and research funding; S.620/H.R.1189, Preserving Employee Wellness Programs Act, issues related to the Genetic Information Act of 2008 and workplace wellness programs; H.R.2846, Planning Actively for Cancer Treatments Act, support coverage of cancer care planning and coordination services; S.91/H.R.4112, Mobile Mammography Promotion Act, issues related to excluding mobile mammography vehicles from the motor fuel excise tax; H.R.3119, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care; S.1488/H.R.2624, Part D Beneficiary Appeals Fairness Act, issues related to out-of-pocket costs for prescription drugs.
2016 · first_quarter · Health Issues
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, H.R.644 - America Gives More Act; and CDC opioid prescription guidelines.
Client expense: $760,000 · Firm income: Not reported
2016 · first_quarter · Health Issues
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, H.R.644 - America Gives More Act; and CDC opioid prescription guidelines.
Client expense: $760,000 · Firm income: Not reported
2016 · first_quarter · Health Issues
Pub. Law No. 111-148, Patient Protection and Affordable Care Act, matters related to the implementation of breast health education, research and clinical trials; S.1566/H.R.2722, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients; H.R.1600, Patients' Access to Treatment Act, support amending the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure and prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier; H.R.1608, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; S.370/H.R.716, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; H.R.1925, Dr. Balazs "Ernie" Bodai Congressional Gold Medal, support the presentation of a congressional gold medal to Dr. Balaz "Ernie" Bodai in recognition of his many outstanding contributions to the nation, including a tireless commitment to breast cancer research; S.1192/H.R.2540, Breast Cancer Patient Education Act, efforts to support creating an educational campaign to inform breast cancer patients anticipating surgery about the availability and coverage of breast reconstruction and prostheses; H.R.6, 21st Century Cures Act, issues related to cancer prevention and research funding; S.620/H.R.1189, Preserving Employee Wellness Programs Act, issues related to the Genetic Information Act of 2008 and workplace wellness programs; H.R.2846, Planning Actively for Cancer Treatments Act, support coverage of cancer care planning and coordination services; S.91/H.R.4112, Mobile Mammography Promotion Act, issues related to excluding mobile mammography vehicles from the motor fuel excise tax; H.R.3119, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care; S.1488/H.R.2624, Part D Beneficiary Appeals Fairness Act, issues related to out-of-pocket costs for prescription drugs.
2016 · first_quarter · Health Issues
Breast Density and Mammography Reporting Act of 2015 (S. 370/H.R. 716).
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Health Issues
Africa Health Systems Strengthening Health Information Technology HR 160 - Protect Medical Innovation Act of 2015 HR 2772 - Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016 HR 320 - Rapid DNA Act of 2015 HR 597 - Reform Exports and Expand the American Economy Act HR 639 - Improving Regulatory Transparency for New Medical Therapies Act HR 716 - Breast Density and Mammography Reporting Act of 2015 S 149 - Medical Device Access and Innovation Protection Act of 2015 S 370 - Breast Density and Mammography Reporting Act of 2015 S 481 - Improving Regulatory Transparency for New Medical Therapies Act S 819 - Export-Import Bank Reform and Reauthorization Act of 2015
Client expense: $4,100,000 · Firm income: Not reported
2015 · fourth_quarter · Health Issues
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, H.R.644 - America Gives More Act; and CDC opioid prescription guidelines.
Client expense: $1,960,000 · Firm income: Not reported
2015 · fourth_quarter · Health Issues
HR 770 - To repeal the Patient Protection and Affordable Care Act and health care-related provisions in the Health Care and Education Reconciliation Act of 2010: entire bill HR 132/S 339 - ObamaCare Repeal Act: entire bill Public Law No. 111-148- Patient Protection and Affordable Care Act: entire law Public Law No. 111-152- Health Care and Education Reconciliation Act of 2010: entire law HR 2 - Medicare Access and CHIP Reauthorization Act SGR Repeal and Medicare Beneficiary Access Act: amendments and provisions related to and affecting reproductive health and family planning HR 1101 - Viral Hepatitis Testing Act: entire bill HR 1502 - Medicare Parity Act: entire bill S 737 - Ensuring Access to Primary Care for Women & Children Act: entire bill HR 117 - Reclaiming Individual Liberty Act: entire bill S 77 - Patient Choice Restoration Act: entire bill S 221 - Pregnancy Assistance Fund Expansion Act: entire bill HR 22 - Hire More Heroes Act: entire bill HR 1356/S 471 - Women Veterans Access to Quality Care Act: entire bill S 469 - Women Veterans and Families Health Services Act: entire bill HR 691 - Telehealth Modernization Act : entire bill HR 768 - Stop AIDS in Prison Act: entire bill HR 45 - Triple-Negative Breast Cancer Research and Education Act: entire bill HR 716/S 370 - Breast Density and Mammography Reporting Act: entire bill HR 1197 - Accelerating the End of Breast Cancer Act: entire bill S 697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act: entire bill S 1016 - Preserving Freedom and Choice in Health Care Act: entire bill HR 2054 - To amend title 38, United States Code, to provide for increased access to Department of Veterans Affairs medical care for women veterans: entire bill HR 2300 - Empowering Patients First Act: entire bill S 1438 - Allowing Greater Access to Safe and Effective Contraception Act: entire bill S Res 193 - A resolution celebrating the 50th anniversary of the historic Griswold v. Connecticut decision of the Supreme Court of the United States and expressing the sense of the Senate that the case was an important step forward in helping ensure that all people of the United States are able to use contraceptives to plan pregnancies and have healthier babies.: entire resolution HR 2653 - American Health Care Reform Act: entire bill HR 3163/S 1532 - Affordability Is Access Act: entire bill HR 2866 - To amend title XXVII of the Public Health Service Act to provide for a special enrollment period for pregnant women, and for other purposes: entire bill HR 6 - 21st Century Cures Act: entire bill HR 2066 - Telehealth Enhancement Act: entire bill HR 1345 - Health IT Modernization for Underserved Communities Act: entire bill HR 270 - Flexibility in Health IT Reporting (Flex-IT) Act: entire bill HR 2646 - Helping Families in Mental Health Crisis Act: entire bill HR 2725 - 21st Century Care for Military and Veterans Act: entire bill HR 2355 - Women's Preventive Health Awareness Campaign: entire bill HR 2820 - Stem Cell Therapeutic and Research Reauthorization Act: entire bill HR 2866/S 2220 - the Healthy MOM Act S 1299/HR 938 - Garrett Lee Smith Memorial Act Reauthorization HR 3171 - To amend the Public Health Service Act to prohibit certain research on the transplantation of human fetal tissue obtained pursuant to an abortion. S 1919 - A bill to amend the Patient Protection and Affordable Care Act to protect rights of conscience with regard to requirements for coverage of specific items and services, to amend the Public Health Service Act to prohibit certain abortion-related discrimination in governmental activities, and for other purposes. HR 3443 - Women's Health Accountability Act HR 2972 - Equal Access to Abortion Coverage in Health Insurance (EACH Woman) Act HR 3498 - Human Cloning Prohibition Act S 1917 - A bill to prohibit the provision of Federal funds to an entity that receives compensation for facilitating the donation of fetal tissue derived from an abortion. H Res 558/S Res 327 - A resolution condemning violence that targets healthcare for women. Reducing Unexpected Deaths in Infants and Children Act of 2015
2015 · third_quarter · Health Issues
Africa Health Systems Strengthening Health Information Technology HR 160 - Protect Medical Innovation Act of 2015 HR 2772 - Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016 HR 320 - Rapid DNA Act of 2015 HR 597 - Reform Exports and Expand the American Economy Act HR 6 - 21st Century Cures HR 639 - Improving Regulatory Transparency for New Medical Therapies Act HR 716 - Breast Density and Mammography Reporting Act of 2015 Laboratory Developed Tests S 149 - Medical Device Access and Innovation Protection Act of 2015 S 370 - Breast Density and Mammography Reporting Act of 2015 S 481 - Improving Regulatory Transparency for New Medical Therapies Act S 819 - Export-Import Bank Reform and Reauthorization Act of 2015
Client expense: $3,470,000 · Firm income: Not reported
2015 · fourth_quarter · Health Issues
Africa Health Systems Strengthening Health Information Technology HR 160 - Protect Medical Innovation Act of 2015 HR 2772 - Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016 HR 320 - Rapid DNA Act of 2015 HR 597 - Reform Exports and Expand the American Economy Act HR 639 - Improving Regulatory Transparency for New Medical Therapies Act HR 716 - Breast Density and Mammography Reporting Act of 2015 S 149 - Medical Device Access and Innovation Protection Act of 2015 S 370 - Breast Density and Mammography Reporting Act of 2015 S 481 - Improving Regulatory Transparency for New Medical Therapies Act S 819 - Export-Import Bank Reform and Reauthorization Act of 2015
Client expense: $4,140,000 · Firm income: Not reported
2015 · fourth_quarter · Health Issues
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, H.R.644 - America Gives More Act; and CDC opioid prescription guidelines.
Client expense: $1,960,000 · Firm income: Not reported
2015 · fourth_quarter · Health Issues
Pub. Law No. 111-148, Patient Protection and Affordable Care Act, matters related to the implementation of breast health education, research and clinical trials; S.1566/H.R.2722, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients; H.R.1600, Patients' Access to Treatment Act, support amending the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure and prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier; H.R.1608, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; S.1170/H.R.2191, Breast Cancer Research Stamp Reauthorization Act, advocate for the reauthorization of the breast cancer research stamp; S.370/H.R.716, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; H.R.1925, Dr. Balazs "Ernie" Bodai Congressional Gold Medal, support the presentation of a congressional gold medal to Dr. Balaz "Ernie" Bodai in recognition of his many outstanding contributions to the nation, including a tireless commitment to breast cancer research; S.1192/H.R.2540, Breast Cancer Patient Education Act, efforts to support creating an educational campaign to inform breast cancer patients anticipating surgery about the availability and coverage of breast reconstruction and prostheses; H.R.6, 21st Century Cures Act, issues related to cancer prevention and research funding; S.620/H.R.1189, Preserving Employee Wellness Programs Act, issues related to the Genetic Information Act of 2008 and workplace wellness programs; S.1926/H.R.3339, Protecting Access to Lifesaving Screenings Act, amends Title XVIII of the Social Security Act to protect coverage for screening mammography; H.R.2846, Planning Actively for Cancer Treatments Act, support coverage of cancer care planning and coordination services; S.91/H.R.4112, Mobile Mammography Promotion Act, issues related to excluding mobile mammography vehicles from the motor fuel excise tax; H.R.3119, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care.
2015 · fourth_quarter · Health Issues
Breast Density and Mammography Reporting Act of 2015 (S. 370/H.R. 716); Breast Cancer Research Stamp Reauthorization Act introduction (H.R. 2191/S. 1170).
Client expense: Not reported · Firm income: $10,000
Government targets: SENATE
2015 · third_quarter · Health Issues
HR 770 - To repeal the Patient Protection and Affordable Care Act and health care-related provisions in the Health Care and Education Reconciliation Act of 2010: entire bill HR 132/S 339 - ObamaCare Repeal Act: entire bill Public Law No. 111-148- Patient Protection and Affordable Care Act: entire law Public Law No. 111-152- Health Care and Education Reconciliation Act of 2010: entire law HR 2 - Medicare Access and CHIP Reauthorization Act SGR Repeal and Medicare Beneficiary Access Act: amendments and provisions related to and affecting reproductive health and family planning HR 1101 - Viral Hepatitis Testing Act: entire bill HR 1502 - Medicare Parity Act: entire bill S 737 - Ensuring Access to Primary Care for Women & Children Act: entire bill HR 117 - Reclaiming Individual Liberty Act: entire bill S 77 - Patient Choice Restoration Act: entire bill S 221 - Pregnancy Assistance Fund Expansion Act: entire bill HR 22 - Hire More Heroes Act: entire bill HR 1356/S 471 - Women Veterans Access to Quality Care Act: entire bill S 469 - Women Veterans and Families Health Services Act: entire bill HR 691 - Telehealth Modernization Act : entire bill HR 768 - Stop AIDS in Prison Act: entire bill HR 45 - Triple-Negative Breast Cancer Research and Education Act: entire bill HR 716/S 370 - Breast Density and Mammography Reporting Act: entire bill HR 1197 - Accelerating the End of Breast Cancer Act: entire bill S 697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act: entire bill S 1016 - Preserving Freedom and Choice in Health Care Act: entire bill HR 2054 - To amend title 38, United States Code, to provide for increased access to Department of Veterans Affairs medical care for women veterans: entire bill HR 2300 - Empowering Patients First Act: entire bill S 1438 - Allowing Greater Access to Safe and Effective Contraception Act: entire bill S Res 193 - A resolution celebrating the 50th anniversary of the historic Griswold v. Connecticut decision of the Supreme Court of the United States and expressing the sense of the Senate that the case was an important step forward in helping ensure that all people of the United States are able to use contraceptives to plan pregnancies and have healthier babies.: entire resolution HR 2653 - American Health Care Reform Act: entire bill HR 3163/S 1532 - Affordability Is Access Act: entire bill HR 2866 - To amend title XXVII of the Public Health Service Act to provide for a special enrollment period for pregnant women, and for other purposes: entire bill HR 6 - 21st Century Cures Act: entire bill HR 2066 - Telehealth Enhancement Act: entire bill HR 1345 - Health IT Modernization for Underserved Communities Act: entire bill HR 270 - Flexibility in Health IT Reporting (Flex-IT) Act: entire bill HR 2646 - Helping Families in Mental Health Crisis Act: entire bill HR 2725 - 21st Century Care for Military and Veterans Act: entire bill HR 2355 - Women's Preventive Health Awareness Campaign: entire bill HR 2820 - Stem Cell Therapeutic and Research Reauthorization Act: entire bill HR 2866 - the Healthy MOM Act S 1299/HR 938 - Garrett Lee Smith Memorial Act Reauthorization HR 3171 - To amend the Public Health Service Act to prohibit certain research on the transplantation of human fetal tissue obtained pursuant to an abortion. S 1919 - A bill to amend the Patient Protection and Affordable Care Act to protect rights of conscience with regard to requirements for coverage of specific items and services, to amend the Public Health Service Act to prohibit certain abortion-related discrimination in governmental activities, and for other purposes. HR 3443 - Women's Health Accountability Act HR 2972 - Equal Access to Abortion Coverage in Health Insurance (EACH Woman) Act HR 3498 - Human Cloning Prohibition Act S 1917 - A bill to prohibit the provision of Federal funds to an entity that receives compensation for facilitating the donation of fetal tissue derived from an abortion.
2015 · first_quarter · Health Issues
21st Century Cures Africa Health Systems Strengthening HR 160 - Protect Medical Innovation Act of 2015 HR 2 - Medicare Access and CHIP Reauthorization Act of 2015 HR 320 - Rapid DNA Act of 2015 HR 639 - Improving Regulatory Transparency for New Medical Therapies Act HR 716 - Breast Density and Mammography Reporting Act of 2015 S 149 - Medical Device Access and Innovation Protection Act of 2015 S 370 - Breast Density and Mammography Reporting Act of 2015 S 481 - Improving Regulatory Transparency for New Medical Therapies Act State and Foreign Operations Appropriations
Client expense: $4,850,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Export-Import Bank of the United States (EXIM Bank), Federal Aviation Administration (FAA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2015 · third_quarter · Health Issues
Africa Health Systems Strengthening Health Information Technology HR 160 - Protect Medical Innovation Act of 2015 HR 2772 - Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016 HR 320 - Rapid DNA Act of 2015 HR 597 - Reform Exports and Expand the American Economy Act HR 6 - 21st Century Cures HR 639 - Improving Regulatory Transparency for New Medical Therapies Act HR 716 - Breast Density and Mammography Reporting Act of 2015 Laboratory Developed Tests S 149 - Medical Device Access and Innovation Protection Act of 2015 S 370 - Breast Density and Mammography Reporting Act of 2015 S 481 - Improving Regulatory Transparency for New Medical Therapies Act S 819 - Export-Import Bank Reform and Reauthorization Act of 2015
Client expense: $3,520,000 · Firm income: Not reported
2015 · third_quarter · Health Issues
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act, and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act; an issues before the CDC, including opioid prescription guidelines.
Client expense: $1,190,000 · Firm income: Not reported
2015 · third_quarter · Health Issues
Pub. Law No. 111-148, Patient Protection and Affordable Care Act, matters related to the implementation of breast health education, research and clinical trials; S.1566/H.R.2739, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients; H.R.1600, Patients' Access to Treatment Act, support amending the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure and prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier; H.R.1608, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; S.1170/H.R.2191, Breast Cancer Research Stamp Reauthorization Act, advocate for the reauthorization of the breast cancer research stamp; S.370/H.R.716, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; H.R.1925, Dr. Balazs "Ernie" Bodai Congressional Gold Medal, support the presentation of a congressional gold medal to Dr. Balaz "Ernie" Bodai in recognition of his many outstanding contributions to the nation, including a tireless commitment to breast cancer research; S.1192/H.R.2540, Breast Cancer Patient Education Act, efforts to support creating an educational campaign to inform breast cancer patients anticipating surgery about the availability and coverage of breast reconstruction and prostheses; H.R.6, 21st Century Cures Act, issues related to cancer prevention and research funding; S.620/H.R.1189, Preserving Employee Wellness Programs Act, issues related to the Genetic Information Act of 2008 and workplace wellness programs; S.1926/H.R.3339, Protecting Access to Lifesaving Screenings Act, amends Title XVIII of the Social Security Act to protect coverage for screening mammography.
2015 · third_quarter · Health Issues
Breast Density and Mammography Reporting Act of 2015 (S. 370/H.R. 716); Breast Cancer Research Stamp Reauthorization Act introduction (H.R. 2191/S. 1170).
Client expense: Not reported · Firm income: $10,000
Government targets: SENATE
2015 · third_quarter · Health Issues
HR 2739/S 1566, Cancer Drug Coverage Parity Act HR 1600, Patient's Access to Treatment Act HR 6, 21st Century Cures Act S 620/HR 1189: Preserving Employee Wellness Programs Act S 370/HR 716: Breast Density and Mammography Reporting Act Diagnostic mammography
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · second_quarter · Health Issues
HR 770 - To repeal the Patient Protection and Affordable Care Act and health care-related provisions in the Health Care and Education Reconciliation Act of 2010: entire bill HR 132/S 339 - ObamaCare Repeal Act: entire bill Public Law No. 111-148- Patient Protection and Affordable Care Act: entire law Public Law No. 111-152- Health Care and Education Reconciliation Act of 2010: entire law HR 2 - Medicare Access and CHIP Reauthorization Act SGR Repeal and Medicare Beneficiary Access Act: amendments and provisions related to and affecting reproductive health and family planning HR 1101 - Viral Hepatitis Testing Act: entire bill HR 1502 - Medicare Parity Act: entire bill S 737 - Ensuring Access to Primary Care for Women & Children Act: entire bill HR 117 - Reclaiming Individual Liberty Act: entire bill S 77 - Patient Choice Restoration Act: entire bill S 221 - Pregnancy Assistance Fund Expansion Act: entire bill HR 22 - Hire More Heroes Act: entire bill HR 1356/S 471 - Women Veterans Access to Quality Care Act: entire bill S 469 - Women Veterans and Families Health Services Act: entire bill HR 691 - Telehealth Modernization Act : entire bill HR 768 - Stop AIDS in Prison Act: entire bill HR 45 - Triple-Negative Breast Cancer Research and Education Act: entire bill HR 716/S 370 - Breast Density and Mammography Reporting Act: entire bill HR 1197 - Accelerating the End of Breast Cancer Act: entire bill S 697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act: entire bill S 1016 - Preserving Freedom and Choice in Health Care Act: entire bill HR 2054 - To amend title 38, United States Code, to provide for increased access to Department of Veterans Affairs medical care for women veterans: entire bill HR 2300 - Empowering Patients First Act: entire bill S 1438 - Allowing Greater Access to Safe and Effective Contraception Act: entire bill S Res 193 - A resolution celebrating the 50th anniversary of the historic Griswold v. Connecticut decision of the Supreme Court of the United States and expressing the sense of the Senate that the case was an important step forward in helping ensure that all people of the United States are able to use contraceptives to plan pregnancies and have healthier babies.: entire resolution HR 2653 - American Health Care Reform Act: entire bill S 1532 - Affordability Is Access Act: entire bill HR 2866 - To amend title XXVII of the Public Health Service Act to provide for a special enrollment period for pregnant women, and for other purposes: entire bill HR 6 - 21st Century Cures Act: entire bill HR 2066 - Telehealth Enhancement Act: entire bill HR 1345 - Health IT Modernization for Underserved Communities Act: entire bill HR 270 - Flexibility in Health IT Reporting (Flex-IT) Act: entire bill HR 2646 - Helping Families in Mental Health Crisis Act: entire bill HR 2725 - 21st Century Care for Military and Veterans Act: entire bill HR 2355 - Women's Preventive Health Awareness Campaign: entire bill HR 2820 - Stem Cell Therapeutic and Research Reauthorization Act: entire bill S 1299/HR 938 - Garrett Lee Smith Memorial Act Reauthorization
2015 · second_quarter · Health Issues
Africa Health Systems Strengthening Health Information Technology HR 160 - Protect Medical Innovation Act of 2015 HR 2 - Medicare Access and CHIP Reauthorization Act of 2015 HR 2772 - Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016 HR 320 - Rapid DNA Act of 2015 HR 597 - Reform Exports and Expand the American Economy Act HR 6 - 21st Century Cures HR 639 - Improving Regulatory Transparency for New Medical Therapies Act HR 644 - Trade Facilitation and Trade Enforcement Act of 2015 HR 716 - Breast Density and Mammography Reporting Act of 2015 Laboratory Developed Tests S 1269 - Trade Facilitation and Trade Enforcement Act of 2015 S 149 - Medical Device Access and Innovation Protection Act of 2015 S 370 - Breast Density and Mammography Reporting Act of 2015 S 481 - Improving Regulatory Transparency for New Medical Therapies Act S 819 - Export-Import Bank Reform and Reauthorization Act of 2015
Client expense: $8,460,000 · Firm income: Not reported
2015 · second_quarter · Health Issues
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including follow-on legislation to H.R.1666 & S.2800, the Patient Centered Quality Care for Life Act, and, H.R.1339 (IH) & S.641, the Palliative Care and Hospice Education and Training Act (113th Congress), H.R.716 & S.370, the Breast Density & Mammography Reporting Act, and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act.
Client expense: $1,310,000 · Firm income: Not reported
2015 · second_quarter · Health Issues
California's pending 1115 Medicaid waiver; the 340B drug discount program and Dense breast tissue bill, S.370/H.R.716.
Client expense: Not reported · Firm income: $50,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
2015 · second_quarter · Health Issues
Pub. Law No. 111-148, Patient Protection and Affordable Care Act, matters related to the implementation of breast health education, research and clinical trials; S.1695/H.R.3020, Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, issues related to cancer prevention and research funding; S.1558/H.R.2685, Department of Defense Appropriations Act, issues related to cancer prevention and research funding; S.1566/H.R.2739, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients; H.R.1600, Patients' Access to Treatment Act, support amending the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure and prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier; H.R.1608, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; S.1170/H.R.2191, Breast Cancer Research Stamp Reauthorization Act, advocate for the reauthorization of the breast cancer research stamp; H.R.2722, Breast Cancer Awareness Commemorative Coin Act, support the creation of a breast cancer awareness coin to increase the funding available for breast cancer research; S.370/H.R.716, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; H.R.1925, Dr. Balazs "Ernie" Bodai Congressional Gold Medal, support the presentation of a congressional gold medal to Dr. Balaz "Ernie" Bodai in recognition of his many outstanding contributions to the nation, including a tireless commitment to breast cancer research; S.1192/H.R.2540, Breast Cancer Patient Education Act, efforts to support creating an educational campaign to inform breast cancer patients anticipating surgery about the availability and coverage of breast reconstruction and prostheses.
2015 · second_quarter · Health Issues
Breast Density and Reporting Act of 2015, Notification of Breast Density to Improve Early Detection of Breast Cancer in Women; S. 370/H.R. 716, Support for Breast Cancer Research Reauthorization Act introduction.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · second_quarter · Health Issues
HR 2739/S 1566, Cancer Drug Coverage Parity Act HR 1600, Patient's Access to Treatment Act HR 6, 21st Century Cures Act S 620/HR 1189: Preserving Employee Wellness Programs Act S 370/HR 716: Breast Density and Mammography Reporting Act Diagnostic mammography
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · first_quarter · Health Issues
No bill number, Cancer Treatment Parity Act HR 1600, Patient's Access to Treatment Act No bill number, 21st Century Cures Act S. 620/HR 1189: Preserving Employee Wellness Programs Act S. 370/HR 716: Breast Density and Mammography Reporting Act Diagnostic mammography
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · first_quarter · Health Issues
California's pending 1115 Medicaid waiver; the 340B drug discount program; infectious disease control, prevention and preparedness; CHIP; protecting Medicaid funding; protecting the Affordable Care Act; and Dense breast tissue bill, S.370
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · first_quarter · Health Issues
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including follow-on legislation to H.R.1666 & S.2800, the Patient Centered Quality Care for Life Act, and, H.R.1339 (IH) & S.641, the Palliative Care and Hospice Education and Training Act (113th Congress), H.R.716 & S.370, the Breast Density & Mammography Reporting Act, and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, colorectal cancer screening tests, electronic medical devices, and issues relating to the 21st Century Cures Initiative of the House Energy & Commerce Committee and Senate HELP Committee.
Client expense: $1,090,000 · Firm income: Not reported
2015 · first_quarter · Health Issues
HR 770 - To repeal the Patient Protection and Affordable Care Act and health care-related provisions in the Health Care and Education Reconciliation Act of 2010: entire bill HR 132/S 339 - ObamaCare Repeal Act: entire bill Public Law No. 111-148- Patient Protection and Affordable Care Act: entire law Public Law No. 111-152- Health Care and Education Reconciliation Act of 2010: entire law HR 2 - Medicare Access and CHIP Reauthorization Act SGR Repeal and Medicare Beneficiary Access Act: amendments and provisions related to and affecting reproductive health and family planning HR 1101 - Viral Hepatitis Testing Act: entire bill HR 1502 - Medicare Parity Act: entire bill S 737 - Ensuring Access to Primary Care for Women & Children Act: entire bill HR 117 - Reclaiming Individual Liberty Act: entire bill S 77 - Patient Choice Restoration Act: entire bill S 221 - Pregnancy Assistance Fund Expansion Act: entire bill HR 22 - Hire More Heroes Act: entire bill HR 1356/S 471 - Women Veterans Access to Quality Care Act: entire bill S 469 - Women Veterans and Families Health Services Act: entire bill HR 691 - Telehealth Modernization Act : entire bill HR 768 - Stop AIDS in Prison Act: entire bill HR 45 - Triple-Negative Breast Cancer Research and Education Act: entire bill HR 716/S 370 - Breast Density and Mammography Reporting Act: entire bill HR 1197 - Accelerating the End of Breast Cancer Act: entire bill S 697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act
Client expense: $119,054 · Firm income: Not reported
2015 · first_quarter · Health Issues
21st Century Cures Africa Health Systems Strengthening HR 160 - Protect Medical Innovation Act of 2015 HR 2 - Medicare Access and CHIP Reauthorization Act of 2015 HR 320 - Rapid DNA Act of 2015 HR 639 - Improving Regulatory Transparency for New Medical Therapies Act HR 716 - Breast Density and Mammography Reporting Act of 2015 S 149 - Medical Device Access and Innovation Protection Act of 2015 S 370 - Breast Density and Mammography Reporting Act of 2015 S 481 - Improving Regulatory Transparency for New Medical Therapies Act State and Foreign Operations Appropriations
Client expense: $4,750,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Export-Import Bank of the United States (EXIM Bank), Federal Aviation Administration (FAA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2015 · first_quarter · Health Issues
No bill number, Cancer Treatment Parity Act HR 1600, Patient's Access to Treatment Act No bill number, 21st Century Cures Act S. 620/HR 1189: Preserving Employee Wellness Programs Act S. 370/HR 716: Breast Density and Mammography Reporting Act Diagnostic mammography
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · first_quarter · Health Issues
Introduction of Breast Density and Reporting Act of 2015, Notification of Breast Density to Improve Early Detection of Breast Cancer in Women; S. 370/H.R. 716, Support for Breast Cancer Research Reauthorization Act introduction.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| NY |
| Claire McCaskill | Democratic | MO |
| Dean Heller | Republican | NV |
| Debbie Stabenow | Democratic | MI |
| Edward J. Markey | Democratic | MA |
| Elizabeth Warren | Democratic | MA |
| Gary C. Peters | Democratic | MI |
| Heidi Heitkamp | Democratic | ND |
| Jeanne Shaheen | Democratic | NH |
| Kelly Ayotte | Republican | NH |
| Kirsten E. Gillibrand | Democratic | NY |
| Maria Cantwell | Democratic | WA |
| Mark Kirk | Republican | IL |
| Mazie K. Hirono | Democratic | HI |
| Richard Blumenthal | Democratic | CT |
| Robert P. Casey, Jr. | Democratic | PA |
| Shelley Moore Capito | Republican | WV |
| Sherrod Brown | Democratic | OH |
| Susan M. Collins | Republican | ME |
| Tammy Baldwin | Democratic | WI |
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Client expense: $39,585 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Client expense: $100,208 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Client expense: $70,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Export-Import Bank of the United States (EXIM Bank), Federal Aviation Administration (FAA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Client expense: $42,941 · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Peace Corps, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA)
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Export-Import Bank of the United States (EXIM Bank), Federal Aviation Administration (FAA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Export-Import Bank of the United States (EXIM Bank), Federal Aviation Administration (FAA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Institutes of Health (NIH), SENATE
Client expense: $278,546 · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Peace Corps, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA)
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Export-Import Bank of the United States (EXIM Bank), Federal Aviation Administration (FAA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Client expense: $40,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Client expense: $172,805 · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Peace Corps, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA)
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Export-Import Bank of the United States (EXIM Bank), Federal Aviation Administration (FAA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Client expense: $80,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Government targets: Administration for Children & Families (ACF), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Peace Corps, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA)